Video

Dr. Andino discusses telehealth for male infertility appointments

Author(s):

Urology Times staff

"None of our patients had unexpected appointments that had to be made after their video encounters…supporting this idea that at least in urology, it seems that telehealth is a substitute for inpatient care when appropriately selected by the physician,” says Juan José Andino, MD.

In this video, Juan José Andino, MD, discusses the background and findings of his study, “Video Visits are Practical for the Follow-up and Management of Established Male Infertility Patients.” Andino is a urology resident at the University of Michigan Hospital-Michigan Medicine, Ann Arbor.

Related Videos
Drug costs | Image Credit: © pixelrobot - stock.adobe.com
Urinary bladder | Image Credit: © magicmine - stock.adobe.com
Hailey Frye answers a question during a Zoom video interview
3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Related Content
Label change for testosterone: Implications for urologists, prescribers, and patients
April 9th 2025

Label change for testosterone: Implications for urologists, prescribers, and patients

Hannah Clarke
In February 2025, the FDA recommended a removal of the black box warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This recommendation has important implications for urologists and the patients they treat.
The urologist's role in dispelling men's health myths
May 10th 2022

The urologist's role in dispelling men's health myths

Urology Times staff
“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.
FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies
March 3rd 2025

FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies

Hannah Clarke
The FDA is requiring a warning about increased blood pressure and is recommending that the black box warning related to the increased risk of adverse cardiovascular events be removed.
Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes
March 7th 2022

Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes

Urology Times staff
“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.
FDA market clearance sought for Separo sealing system for vasectomy
January 29th 2025

FDA market clearance sought for Separo sealing system for vasectomy

Matthew J. Mutter, MD
"The biggest thing that I took away from using the device is that it allowed me to do the procedure by myself, without an assistant," says Matthew J. Mutter, MD.
FDA clears chemiluminescence-based immunoassay for free testosterone
January 10th 2025

FDA clears chemiluminescence-based immunoassay for free testosterone

Hannah Clarke
The test can provide results in 48 minutes for diagnostic insights for conditions such as hypogonadism, impotence, polycystic ovarian syndrome, and other androgenital syndromes.
© 2025 MJH Life Sciences

All rights reserved.